Cerebrovascular Reactivity to L-Arginine in Patients with Lacunar Infarctions
Background: It is well known that endothelial dysfunction plays an important role in the pathogenesis of many cardiovascular disorders. The aim of this study was to test the hypothesis that specific, marked endothelial dysfunction of cerebral arteries is present in patients with lacunar cerebral inf...
Gespeichert in:
Veröffentlicht in: | Cerebrovascular diseases (Basel, Switzerland) Switzerland), 2006-01, Vol.21 (3), p.180-186 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 186 |
---|---|
container_issue | 3 |
container_start_page | 180 |
container_title | Cerebrovascular diseases (Basel, Switzerland) |
container_volume | 21 |
creator | Pretnar-Oblak, Janja Zaletel, Marjan Zvan, Bojana Sabovic, Miso Pogacnik, Tomaz |
description | Background: It is well known that endothelial dysfunction plays an important role in the pathogenesis of many cardiovascular disorders. The aim of this study was to test the hypothesis that specific, marked endothelial dysfunction of cerebral arteries is present in patients with lacunar cerebral infarctions. Methods: Cerebrovascular reactivity to L-arginine, which reveals the function of the cerebral endothelium, was investigated in patients with lacunar infarctions (20 patients, 11 male and 9 female, aged 60.9 ± 7.3 years), 21 age- and gender-matched asymptomatic patients with similar cardiovascular risk factors (all patients had arterial hypertension) and 21 age- and gender-matched healthy controls. The mean arterial velocity (v m ) in both middle cerebral arteries was measured by transcranial Doppler sonography during a 15-min baseline period, a 30-min intravenous infusion of L-arginine and a 15-min interval after L-arginine infusion. Arterial blood pressure, heart rate and CO 2 were measured continuously. Results: The measured v m increase during L-arginine infusion in the patients with lacunar infarctions (13.4 ± 9.1%) was significantly lower compared to the healthy controls (20.5 ± 9.9%) but similar to that obtained in the patients with cardiovascular risk factors (11.5 ± 8.9%). Conclusions: Our results showed that cerebrovascular reactivity to L-arginine, which demonstrates cerebral endothelial function, is significantly impaired in patients with cardiovascular risk factors. Importantly, we found that patients with lacunar infarctions do not show any additional impairment of cerebral endothelial function. |
doi_str_mv | 10.1159/000090530 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_221226448</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>992056661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-29da71f06226dab37fffb180638944bc2f7a262bdf6f91a5d12dd87f93d0c8d03</originalsourceid><addsrcrecordid>eNqF0c1LwzAUAPAgipvTg2dBigfBQzUvbdPkOIYfg4kiei5pk8zMLp1JO9l_b6RjghdzyTv83uN9IHQK-Bog4zc4PI6zBO-hIaQEYp4zuh9iDFmIczxAR94vgqLA4BANgCaMAU-G6HGinCpdsxa-6mrhohclqtasTbuJ2iaaxWM3N9ZYFRkbPYvWKNv66Mu079FMVJ0NGVOrhQs5jfXH6ECL2quT7T9Cb3e3r5OHePZ0P52MZ3GVUGhjwqXIQWNKCJWiTHKtdQkMh654mpYV0bkglJRSU81BZBKIlCzXPJG4YhInI3TZ11255rNTvi2WxleqroVVTecLmlMGBP8PSdhbyikN8OIPXDSds2GIghAIfaYpC-iqR5VrvHdKFytnlsJtCsDFzyWK3SWCPd8W7Mqlkr9yu_oAznrwIdxcuR3o078BP1WK3Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221226448</pqid></control><display><type>article</type><title>Cerebrovascular Reactivity to L-Arginine in Patients with Lacunar Infarctions</title><source>MEDLINE</source><source>Karger Online</source><creator>Pretnar-Oblak, Janja ; Zaletel, Marjan ; Zvan, Bojana ; Sabovic, Miso ; Pogacnik, Tomaz</creator><creatorcontrib>Pretnar-Oblak, Janja ; Zaletel, Marjan ; Zvan, Bojana ; Sabovic, Miso ; Pogacnik, Tomaz</creatorcontrib><description>Background: It is well known that endothelial dysfunction plays an important role in the pathogenesis of many cardiovascular disorders. The aim of this study was to test the hypothesis that specific, marked endothelial dysfunction of cerebral arteries is present in patients with lacunar cerebral infarctions. Methods: Cerebrovascular reactivity to L-arginine, which reveals the function of the cerebral endothelium, was investigated in patients with lacunar infarctions (20 patients, 11 male and 9 female, aged 60.9 ± 7.3 years), 21 age- and gender-matched asymptomatic patients with similar cardiovascular risk factors (all patients had arterial hypertension) and 21 age- and gender-matched healthy controls. The mean arterial velocity (v m ) in both middle cerebral arteries was measured by transcranial Doppler sonography during a 15-min baseline period, a 30-min intravenous infusion of L-arginine and a 15-min interval after L-arginine infusion. Arterial blood pressure, heart rate and CO 2 were measured continuously. Results: The measured v m increase during L-arginine infusion in the patients with lacunar infarctions (13.4 ± 9.1%) was significantly lower compared to the healthy controls (20.5 ± 9.9%) but similar to that obtained in the patients with cardiovascular risk factors (11.5 ± 8.9%). Conclusions: Our results showed that cerebrovascular reactivity to L-arginine, which demonstrates cerebral endothelial function, is significantly impaired in patients with cardiovascular risk factors. Importantly, we found that patients with lacunar infarctions do not show any additional impairment of cerebral endothelial function.</description><identifier>ISSN: 1015-9770</identifier><identifier>EISSN: 1421-9786</identifier><identifier>DOI: 10.1159/000090530</identifier><identifier>PMID: 16388193</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Aged ; Arginine - administration & dosage ; Arginine - pharmacology ; Blood Flow Velocity ; Blood Pressure - drug effects ; Brain Infarction - physiopathology ; Carbon Dioxide - analysis ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - physiopathology ; Case-Control Studies ; Cerebral Arteries - physiology ; Cerebrovascular Circulation - drug effects ; Endothelial Cells - drug effects ; Endothelial Cells - physiology ; Female ; Heart Rate - drug effects ; Heart Rate - physiology ; Humans ; Infusions, Intravenous ; Male ; Middle Aged ; Nitric Oxide - metabolism ; Nitric Oxide Synthase - physiology ; Original Paper ; Risk Factors ; Time Factors ; Ultrasonography, Doppler, Transcranial</subject><ispartof>Cerebrovascular diseases (Basel, Switzerland), 2006-01, Vol.21 (3), p.180-186</ispartof><rights>2006 S. Karger AG, Basel</rights><rights>Copyright 2006 S. Karger AG, Basel.</rights><rights>Copyright (c) 2006 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-29da71f06226dab37fffb180638944bc2f7a262bdf6f91a5d12dd87f93d0c8d03</citedby><cites>FETCH-LOGICAL-c361t-29da71f06226dab37fffb180638944bc2f7a262bdf6f91a5d12dd87f93d0c8d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,2429,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16388193$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pretnar-Oblak, Janja</creatorcontrib><creatorcontrib>Zaletel, Marjan</creatorcontrib><creatorcontrib>Zvan, Bojana</creatorcontrib><creatorcontrib>Sabovic, Miso</creatorcontrib><creatorcontrib>Pogacnik, Tomaz</creatorcontrib><title>Cerebrovascular Reactivity to L-Arginine in Patients with Lacunar Infarctions</title><title>Cerebrovascular diseases (Basel, Switzerland)</title><addtitle>Cerebrovasc Dis</addtitle><description>Background: It is well known that endothelial dysfunction plays an important role in the pathogenesis of many cardiovascular disorders. The aim of this study was to test the hypothesis that specific, marked endothelial dysfunction of cerebral arteries is present in patients with lacunar cerebral infarctions. Methods: Cerebrovascular reactivity to L-arginine, which reveals the function of the cerebral endothelium, was investigated in patients with lacunar infarctions (20 patients, 11 male and 9 female, aged 60.9 ± 7.3 years), 21 age- and gender-matched asymptomatic patients with similar cardiovascular risk factors (all patients had arterial hypertension) and 21 age- and gender-matched healthy controls. The mean arterial velocity (v m ) in both middle cerebral arteries was measured by transcranial Doppler sonography during a 15-min baseline period, a 30-min intravenous infusion of L-arginine and a 15-min interval after L-arginine infusion. Arterial blood pressure, heart rate and CO 2 were measured continuously. Results: The measured v m increase during L-arginine infusion in the patients with lacunar infarctions (13.4 ± 9.1%) was significantly lower compared to the healthy controls (20.5 ± 9.9%) but similar to that obtained in the patients with cardiovascular risk factors (11.5 ± 8.9%). Conclusions: Our results showed that cerebrovascular reactivity to L-arginine, which demonstrates cerebral endothelial function, is significantly impaired in patients with cardiovascular risk factors. Importantly, we found that patients with lacunar infarctions do not show any additional impairment of cerebral endothelial function.</description><subject>Aged</subject><subject>Arginine - administration & dosage</subject><subject>Arginine - pharmacology</subject><subject>Blood Flow Velocity</subject><subject>Blood Pressure - drug effects</subject><subject>Brain Infarction - physiopathology</subject><subject>Carbon Dioxide - analysis</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Cardiovascular Diseases - physiopathology</subject><subject>Case-Control Studies</subject><subject>Cerebral Arteries - physiology</subject><subject>Cerebrovascular Circulation - drug effects</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelial Cells - physiology</subject><subject>Female</subject><subject>Heart Rate - drug effects</subject><subject>Heart Rate - physiology</subject><subject>Humans</subject><subject>Infusions, Intravenous</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase - physiology</subject><subject>Original Paper</subject><subject>Risk Factors</subject><subject>Time Factors</subject><subject>Ultrasonography, Doppler, Transcranial</subject><issn>1015-9770</issn><issn>1421-9786</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqF0c1LwzAUAPAgipvTg2dBigfBQzUvbdPkOIYfg4kiei5pk8zMLp1JO9l_b6RjghdzyTv83uN9IHQK-Bog4zc4PI6zBO-hIaQEYp4zuh9iDFmIczxAR94vgqLA4BANgCaMAU-G6HGinCpdsxa-6mrhohclqtasTbuJ2iaaxWM3N9ZYFRkbPYvWKNv66Mu079FMVJ0NGVOrhQs5jfXH6ECL2quT7T9Cb3e3r5OHePZ0P52MZ3GVUGhjwqXIQWNKCJWiTHKtdQkMh654mpYV0bkglJRSU81BZBKIlCzXPJG4YhInI3TZ11255rNTvi2WxleqroVVTecLmlMGBP8PSdhbyikN8OIPXDSds2GIghAIfaYpC-iqR5VrvHdKFytnlsJtCsDFzyWK3SWCPd8W7Mqlkr9yu_oAznrwIdxcuR3o078BP1WK3Q</recordid><startdate>20060101</startdate><enddate>20060101</enddate><creator>Pretnar-Oblak, Janja</creator><creator>Zaletel, Marjan</creator><creator>Zvan, Bojana</creator><creator>Sabovic, Miso</creator><creator>Pogacnik, Tomaz</creator><general>S. Karger AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20060101</creationdate><title>Cerebrovascular Reactivity to L-Arginine in Patients with Lacunar Infarctions</title><author>Pretnar-Oblak, Janja ; Zaletel, Marjan ; Zvan, Bojana ; Sabovic, Miso ; Pogacnik, Tomaz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-29da71f06226dab37fffb180638944bc2f7a262bdf6f91a5d12dd87f93d0c8d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Aged</topic><topic>Arginine - administration & dosage</topic><topic>Arginine - pharmacology</topic><topic>Blood Flow Velocity</topic><topic>Blood Pressure - drug effects</topic><topic>Brain Infarction - physiopathology</topic><topic>Carbon Dioxide - analysis</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Cardiovascular Diseases - physiopathology</topic><topic>Case-Control Studies</topic><topic>Cerebral Arteries - physiology</topic><topic>Cerebrovascular Circulation - drug effects</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelial Cells - physiology</topic><topic>Female</topic><topic>Heart Rate - drug effects</topic><topic>Heart Rate - physiology</topic><topic>Humans</topic><topic>Infusions, Intravenous</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase - physiology</topic><topic>Original Paper</topic><topic>Risk Factors</topic><topic>Time Factors</topic><topic>Ultrasonography, Doppler, Transcranial</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pretnar-Oblak, Janja</creatorcontrib><creatorcontrib>Zaletel, Marjan</creatorcontrib><creatorcontrib>Zvan, Bojana</creatorcontrib><creatorcontrib>Sabovic, Miso</creatorcontrib><creatorcontrib>Pogacnik, Tomaz</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Cerebrovascular diseases (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pretnar-Oblak, Janja</au><au>Zaletel, Marjan</au><au>Zvan, Bojana</au><au>Sabovic, Miso</au><au>Pogacnik, Tomaz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cerebrovascular Reactivity to L-Arginine in Patients with Lacunar Infarctions</atitle><jtitle>Cerebrovascular diseases (Basel, Switzerland)</jtitle><addtitle>Cerebrovasc Dis</addtitle><date>2006-01-01</date><risdate>2006</risdate><volume>21</volume><issue>3</issue><spage>180</spage><epage>186</epage><pages>180-186</pages><issn>1015-9770</issn><eissn>1421-9786</eissn><abstract>Background: It is well known that endothelial dysfunction plays an important role in the pathogenesis of many cardiovascular disorders. The aim of this study was to test the hypothesis that specific, marked endothelial dysfunction of cerebral arteries is present in patients with lacunar cerebral infarctions. Methods: Cerebrovascular reactivity to L-arginine, which reveals the function of the cerebral endothelium, was investigated in patients with lacunar infarctions (20 patients, 11 male and 9 female, aged 60.9 ± 7.3 years), 21 age- and gender-matched asymptomatic patients with similar cardiovascular risk factors (all patients had arterial hypertension) and 21 age- and gender-matched healthy controls. The mean arterial velocity (v m ) in both middle cerebral arteries was measured by transcranial Doppler sonography during a 15-min baseline period, a 30-min intravenous infusion of L-arginine and a 15-min interval after L-arginine infusion. Arterial blood pressure, heart rate and CO 2 were measured continuously. Results: The measured v m increase during L-arginine infusion in the patients with lacunar infarctions (13.4 ± 9.1%) was significantly lower compared to the healthy controls (20.5 ± 9.9%) but similar to that obtained in the patients with cardiovascular risk factors (11.5 ± 8.9%). Conclusions: Our results showed that cerebrovascular reactivity to L-arginine, which demonstrates cerebral endothelial function, is significantly impaired in patients with cardiovascular risk factors. Importantly, we found that patients with lacunar infarctions do not show any additional impairment of cerebral endothelial function.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>16388193</pmid><doi>10.1159/000090530</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1015-9770 |
ispartof | Cerebrovascular diseases (Basel, Switzerland), 2006-01, Vol.21 (3), p.180-186 |
issn | 1015-9770 1421-9786 |
language | eng |
recordid | cdi_proquest_journals_221226448 |
source | MEDLINE; Karger Online |
subjects | Aged Arginine - administration & dosage Arginine - pharmacology Blood Flow Velocity Blood Pressure - drug effects Brain Infarction - physiopathology Carbon Dioxide - analysis Cardiovascular Diseases - epidemiology Cardiovascular Diseases - physiopathology Case-Control Studies Cerebral Arteries - physiology Cerebrovascular Circulation - drug effects Endothelial Cells - drug effects Endothelial Cells - physiology Female Heart Rate - drug effects Heart Rate - physiology Humans Infusions, Intravenous Male Middle Aged Nitric Oxide - metabolism Nitric Oxide Synthase - physiology Original Paper Risk Factors Time Factors Ultrasonography, Doppler, Transcranial |
title | Cerebrovascular Reactivity to L-Arginine in Patients with Lacunar Infarctions |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T21%3A25%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cerebrovascular%20Reactivity%20to%20L-Arginine%20in%20Patients%20with%20Lacunar%20Infarctions&rft.jtitle=Cerebrovascular%20diseases%20(Basel,%20Switzerland)&rft.au=Pretnar-Oblak,%20Janja&rft.date=2006-01-01&rft.volume=21&rft.issue=3&rft.spage=180&rft.epage=186&rft.pages=180-186&rft.issn=1015-9770&rft.eissn=1421-9786&rft_id=info:doi/10.1159/000090530&rft_dat=%3Cproquest_cross%3E992056661%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=221226448&rft_id=info:pmid/16388193&rfr_iscdi=true |